felzartamab: Clinical Trials

4 trials of felzartamab, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

2 recruiting, 1 active not recruiting, 1 enrolling by invitation. 4 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	4	Recruiting 2, Active not recruiting 1, Enrolling by invitation 1

Follow felzartamab: new trials by email Literature Review of felzartamab trials Research Report on felzartamab

Trials (filtered) newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Learn More About the Long-Term Safety and Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) or Microvascular Inflammation (MVI) (TRANSCEND/TRANSPIRE LTE) Felzartamab - Antibody-mediated Rejection, Microvascular Inflammation	Phase 3	Enrolling by invitation	Biogen	201	2026-04-16	2026-11-02
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN) Felzartamab, Tacrolimus, Standard of Care IST - Primary Membranous Nephropathy	Phase 3	Recruiting	Biogen	180	2025-05-22	2026-09-29
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) Felzartamab, Placebo - Immunoglobulin A Nephropathy (IgAN)	Phase 3	Recruiting	Biogen	454	2025-05-08	2026-10-14
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) Felzartamab, Placebo - Antibody-mediated Rejection	Phase 3	Active not recruiting	Biogen	132	2024-12-03	2026-06-05

Conditions studied

Sponsors

Countries

Results publications